Carcinogenesis Advance Access originally published online on May 18, 2006
Carcinogenesis 2006 27(6):1126-1127; doi:10.1093/carcin/bgl020
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2006. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
ANTHONY DIPPLE CARCINOGENESIS AWARD |
Cancer prevention: strategy for the future
Department of Medicine, Department of Cell/Developmental Biology and Department of Cancer Biology, The Vanderbilt-Ingram Cancer Center, Nashville, TN 37232, USA
To whom correspondence to be addressed at: The Vanderbilt-Ingram Cancer Center, 698 Preston Research Building, 2300 Pierce Avenue, Nashville, TN 37232-6838, USA Email: raymond.dubois@vanderbilt.edu
| The first 10% of the full text of this article appears below. |
Practicing physicians today are mostly focused on caring for patients who present with symptoms of advanced or chronic diseases like cancer. However, over the past several years, the idea of prevention has been worming its way into our collective psyche. Many of us have begun to think that we may be able to devise ways to detect and treat many different types of cancer before they reach advanced stages. Is this really possible? Considering the rapid progress being made in genomic and proteomic technology, there might be reason to hope that we will assess